BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10385459)

  • 1. Prolonged neuromuscular blockade associated with rocuronium.
    Lewis KS; Santucci VN; Normoyle DL; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jun; 56(11):1114-8. PubMed ID: 10385459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 4. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
    Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
    Leonard PA; Todd MM
    A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of intraoperative rocuronium doses on 30-day postoperative complications after sugammadex reversal in patients undergoing gastrointestinal surgery.
    Onoe K; Ogata H; Ishimoto D; Kaneko T; Ueki R; Kariya N; Tatara T; Hirose M
    J Clin Anesth; 2020 May; 61():109662. PubMed ID: 31759814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause].
    Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H
    Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the pretreatment of magnesium sulphate affect the sugammadex reversal time for rocuronium-induced neuromuscular blockade? A meta-analysis.
    Miao M; Zhang J
    J Clin Anesth; 2020 Mar; 60():78-79. PubMed ID: 31476625
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of subcutaneous infiltration of rocuronium: A case report.
    Timmermann TN; Mongan PD; Hoefnagel AL; Braunecker S
    J Clin Anesth; 2021 Aug; 71():110203. PubMed ID: 33609852
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
    Dewachter P; Mouton-Faivre C
    Anesthesiology; 2015 Sep; 123(3):735-6. PubMed ID: 26284871
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaphylactic reaction to rocuronium bromide.
    Yee R; Fernandez JA
    Anaesth Intensive Care; 1996 Oct; 24(5):601-4. PubMed ID: 8909675
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged residual paralysis after a single intubating dose of rocuronium.
    Claudius C; Karacan H; Viby-Mogensen J
    Br J Anaesth; 2007 Oct; 99(4):514-7. PubMed ID: 17675361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
    Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
    J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy].
    Komasawa N; Noma H; Sugi T; Sukenaga N; Kakiuchi H
    Masui; 2011 Apr; 60(4):476-9. PubMed ID: 21520600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 16. A further case of rocuronium-induced anaphylaxis treated with sugammadex.
    Funnell AE; Griffiths J; Hodzovic I
    Br J Anaesth; 2011 Aug; 107(2):275-6. PubMed ID: 21757555
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High need for sugammadex for rocuronium reversal with acute renal failure and normal need in the same patient with no renal impairment.
    Valente A
    J Clin Anesth; 2020 Dec; 67():109981. PubMed ID: 32682252
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.